Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 52 of 1,261
  1. US 12264344

    Protein/oligonucleotide core-shell nanoparticle therapeutics

    Northwestern University · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted
  2. US 12264343

    TCRa homing endonuclease variants

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted
  3. US 12264322

    Minimal volume reprogramming of mononuclear cells

    Fate Therapeutics, Inc. · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted
  4. US 12264187

    Compositions and methods for targeted therapeutic delivery to bone

    Theradaptive, Inc. · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted
  5. US 12264169

    Heteroaryl inhibitors of PDE4

    Tetra Discovery Partners · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted
  6. US 12263169

    Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted
  7. US 12263180

    Method for treatment of COVID-19-associated conditions

    Rigel Pharmaceuticals, Inc. · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted
  8. US 12263202

    Method of treating melanocortin-4 receptor pathway-associated disorders

    RHYTHM PHARMACEUTICALS, INC. · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted
  9. US 12264336

    Platform for generating safe cell therapeutics

    The Regents of the University of California · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted
  10. US 12263139

    Use of cannabidiol in the treatment of tuberous sclerosis complex

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted
  11. US 12263159

    Fused ring compound having urea structure

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted
  12. US 12263143

    Ionic channel modulation as a method for treating tumors through inflammasome activation

    INSTITUT PASTEUR DE MONTEVIDEO · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted
  13. US 12263243

    Templated open flocs of anisotropic particles for enhanced pulmonary delivery

    The Board of Regents of the University of Texas System · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted
  14. US 12263227

    Optimized mRNA encoding CAS9 for use in LNPs

    CRISPR THERAPEUTICS AG · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted
  15. TW 202513047

    KAT6 inhibitors

    BEIGENE SWITZERLAND GMBH [CH] · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted
  16. US 12264159

    Functionalized heterocycles as antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted
  17. WO 2025062334

    DÉRIVÉS DE 4-((5-(3-(4-(PYRIDIN-2-YL)CYCLOPENTYL)-1 H-PYRAZOL-3-YL)AMINO)-BENZÈNESULFONAMIDE ET COMPOSÉS SIMILAIRES UTILISÉS COMME INHIBITEURS DE CDK POUR LE TRAITEMENT DU CANCER

    BEIGENE SWITZERLAND GMBH [CH] · Granted Mar 27, 2025 · Expires Mar 22, 2045

    granted
  18. WO 2025064824

    MÉTHODES DE TRAITEMENT DE LA MALADIE D'ALZHEIMER

    BIOGEN MA INC [US] · Granted Mar 27, 2025 · Expires Mar 22, 2045

    granted
  19. AR 131518

    COMPUESTO DE 4-AMINOPIPERIDINA, NANOPARTÍCULAS LIPÍDICAS DEL MISMO Y COMPOSICIÓN FARMACÉUTICA QUE CONTIENE EL MISMO

    ASTELLAS PHARMA INC [JP] · Granted Mar 26, 2025 · Expires Mar 21, 2045

    granted
  20. US 12257263

    Pharmaceutical compositions for demodex related blepharitis and eyelid crusting

    Tarsus Pharmaceuticals, Inc. · Granted Mar 25, 2025 · Expires Mar 20, 2045

    granted
  21. US 12258366

    Bicyclic heteroaryl compounds and uses thereof

    Revolution Medicines, Inc. · Granted Mar 25, 2025 · Expires Mar 20, 2045

    granted
  22. US 12257235

    Methods and materials for using ruminococcus gnavus or clostridium sporogenes to treat gastrointestinal disorders

    The Regents of the University of California · Granted Mar 25, 2025 · Expires Mar 20, 2045

    granted
  23. US 12257311

    Multimeric T-cell modulatory polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Mar 25, 2025 · Expires Mar 20, 2045

    granted
  24. US 12256720

    Humanized dipeptidyl-peptidase IV (DPP4) animals

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 25, 2025 · Expires Mar 20, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.